A 2025 JAMA Network Open study analyzing two years of paid search results found that 11% of the search keywords or phrases paid for by Novo Nordisk contained the word "weight", even though the drug Ozempic is approved for type 2 diabetes and not for weight loss.
November 04, 2025
high
statistical
Analysis of paid search (sponsored) results purchased by a pharmaceutical manufacturer.